Well thank you, Clive. Next slide please. Next slide. I've just returned from a five-week trip to the US, and I'm eight days into my 14-day hotel quarantine. Speaking of keeping Australia safe, here is our safe harbour statement. Next slide, please. I want to thank the Finance News Network for the opportunity to provide you a brief overview of Cyclopharm. Whilst 15 minutes can't cover the clinical depth and commercial potential of Technegas®, I have, for your convenience, provided numerous references throughout these slides for you to do your own homework. Furthermore, we're going to launch this presentation on our website.